A longitudinal study of the association of epidural anesthesia and low-dose synthetic oxytocin regimens with breast milk supply and breastfeeding rates

• Published in: Scientific reports Vol. 13; no. 1; p. 21146
• Main Authors: Takahata, Kaori, Horiuchi, Shigeko, Miyauchi, Ai, Tadokoro, Yuriko, Shuo, Takuya
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 30.11.2023; Nature Portfolio
• Subjects: Anesthesia; Anesthesia, Epidural; Apgar score; Breast Feeding; Breast milk; Breastfeeding & lactation; Cesarean Section; Child; Clinical trials; Epidural; Female; Hormones; Humans; Infant, Newborn; Longitudinal Studies; Maternal & child health; Milk, Human; Neonates; Oxytocin; Oxytocin - pharmacology; Postpartum; Postpartum Period; Pregnancy; Womens health
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-48584-6

Breastfeeding is known to improve maternal and child health. However, epidural anesthesia (EDA) and synthetic oxytocin (synOT) are suggested to have negative effects on breastfeeding. In this study, we aimed to determine the effects of intrapartum synOT and EDA on breast milk supply, breastfeeding rates, and maternal salivary oxytocin levels. Women were recruited during pregnancy or after birth at a single hospital. Data were collected at 3 days postpartum (T1), 1 month postpartum (T2), and 4 months postpartum (T3) on 83 low-risk primiparous women who planned to breastfeed for at least 12 weeks postpartum to avoid dropouts from early discontinuance of breastfeeding. Women with cesarean section, twin pregnancy, premature neonates, and an Apgar score of < 7 at 5 min were excluded. Participants recorded their 24-h milk supply by test weights at 3 days and 1 month postpartum. Additionally, they filled out questionnaires assessing their breastfeeding level and lactogenesis stage II initiation. Salivary oxytocin levels were obtained at 3 days postpartum. Women who delivered using EDA had lower salivary oxytocin levels (P = .055, d = .442), breast milk supply in early postpartum (P = .025, d = .520) and at 1 month postpartum (P = .036, d = .483), and breastfeeding rates at 4 months postpartum (P = .037, V = .236) than women who did not deliver using EDA. There was no association between breastfeeding and the use of intrapartum synOT. In conclusion, this study showed that women who delivered using EDA had lower breast milk supply in the early postpartum period and breastfeeding rates at 4 months postpartum. It also revealed that using synOT at low doses during labor did not affect breastfeeding. Thus, women who deliver using EDA need support for increased breast milk supply in the early postpartum period.Trial registration: UMIN000037783 (Clinical Trials Registry of University Hospital Information Network).